重型颅脑损伤-话题@MedSci

#重型颅脑损伤#

8篇内容 | 708人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1633036, encodeId=a2bb163303671, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=JAMA子刊：脑脊液分流治疗重型颅脑损伤患儿的疗效比较, objectType=article, longId=732002, objectId=e305e3200255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e305e3200255, replyNumber=0, likeNumber=54, createdTime=2022-10-19, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e305e3200255, moduleTitle=JAMA子刊：脑脊液分流治疗重型颅脑损伤患儿的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e305e3200255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633035, encodeId=e2e91633035d8, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=Clinica Chimica Acta：血清白介素-33作为重型颅脑损伤预后指标的有效性如何？, objectType=article, longId=183499, objectId=1742183499a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1742183499a2, replyNumber=0, likeNumber=31, createdTime=2020-07-24, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1742183499a2, moduleTitle=Clinica Chimica Acta：血清白介素-33作为重型颅脑损伤预后指标的有效性如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1742183499a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633033, encodeId=def3163303341, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=Clinica Chimica Acta：重型颅脑损伤患者血清可溶性TWEAK水平及其预后意义, objectType=article, longId=179837, objectId=5f7e1e98371c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7e1e98371c, replyNumber=0, likeNumber=38, createdTime=2020-01-18, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7e1e98371c, moduleTitle=Clinica Chimica Acta：重型颅脑损伤患者血清可溶性TWEAK水平及其预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7e1e98371c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633034, encodeId=a4ec1633034d7, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=Clinica Chimica Acta：较高的血浆c型凝集素样受体2浓度预测孤立性重型颅脑损伤患者30天死亡率的较高风险, objectType=article, longId=181547, objectId=1e8d18154eb4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e8d18154eb4, replyNumber=0, likeNumber=30, createdTime=2020-08-22, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e8d18154eb4, moduleTitle=Clinica Chimica Acta：较高的血浆c型凝集素样受体2浓度预测孤立性重型颅脑损伤患者30天死亡率的较高风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e8d18154eb4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633032, encodeId=9306163303275, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=Clinica Chimica Acta：血清分泌酸性蛋白及富含半胱氨酸样蛋白1作为重型颅脑损伤预后指标, objectType=article, longId=177019, objectId=d23d1e701965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d23d1e701965, replyNumber=0, likeNumber=0, createdTime=2019-11-13, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d23d1e701965, moduleTitle=Clinica Chimica Acta：血清分泌酸性蛋白及富含半胱氨酸样蛋白1作为重型颅脑损伤预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d23d1e701965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633031, encodeId=7fe9163303142, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=《第4版美国重型颅脑损伤诊疗指南》解读, objectType=article, longId=131493, objectId=536c13149379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=536c13149379, replyNumber=0, likeNumber=38, createdTime=2018-08-08, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=536c13149379, moduleTitle=《第4版美国重型颅脑损伤诊疗指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=536c13149379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633030, encodeId=4bd916330307f, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=美国第四版《重型颅脑损伤救治指南》解读, objectType=article, longId=128547, objectId=cecf12854e56, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cecf12854e56, replyNumber=0, likeNumber=26, createdTime=2018-06-05, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cecf12854e56, moduleTitle=美国第四版《重型颅脑损伤救治指南》解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cecf12854e56)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633029, encodeId=14b21633029a2, content=<a href='/topic/show?id=828795e2833' target=_blank style='color:#2F92EE;'>#重型颅脑损伤#</a>, objectTitle=Crit Care：重型颅脑损伤患者出现ARDS的血浆标志物研究, objectType=article, longId=77955, objectId=4499e795592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4499e795592, replyNumber=0, likeNumber=41, createdTime=2016-09-30, rootId=0, userName=qblt, userId=c3fa21990661, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4499e795592, moduleTitle=Crit Care：重型颅脑损伤患者出现ARDS的血浆标志物研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4499e795592)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

重型颅脑损伤

2020-05-29

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

JAMA子刊：脑脊液分流治疗重型颅脑损伤患儿的疗效比较

2022-10-19

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

Clinica Chimica Acta：血清白介素-33作为重型颅脑损伤预后指标的有效性如何？

2020-07-24

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

Clinica Chimica Acta：重型颅脑损伤患者血清可溶性TWEAK水平及其预后意义

2020-01-18

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

Clinica Chimica Acta：较高的血浆c型凝集素样受体2浓度预测孤立性重型颅脑损伤患者30天死亡率的较高风险

2020-08-22

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

Clinica Chimica Acta：血清分泌酸性蛋白及富含半胱氨酸样蛋白1作为重型颅脑损伤预后指标

2019-11-13

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

《第4版美国重型颅脑损伤诊疗指南》解读

2018-08-08

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

美国第四版《重型颅脑损伤救治指南》解读

2018-06-05

qblt (审核中...)

前往app查看评论内容

#重型颅脑损伤#

Crit Care：重型颅脑损伤患者出现ARDS的血浆标志物研究

2016-09-30

科室
- - 订阅+
  - 更多科室
工具
服务